Form 8-K - Current report:
SEC Accession No. 0001193125-21-094652
Filing Date
2021-03-25
Accepted
2021-03-25 17:26:03
Documents
14
Period of Report
2021-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d120772d8k.htm   iXBRL 8-K 31658
2 EX-4.1 d120772dex41.htm EX-4.1 941316
3 EX-10.1 d120772dex101.htm EX-10.1 1322561
  Complete submission text file 0001193125-21-094652.txt   2921756

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA endp-20210325.xsd EX-101.SCH 3057
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE endp-20210325_lab.xml EX-101.LAB 18839
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endp-20210325_pre.xml EX-101.PRE 11830
7 EXTRACTED XBRL INSTANCE DOCUMENT d120772d8k_htm.xml XML 3503
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

EIN.: 680683755 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 21773624
SIC: 2834 Pharmaceutical Preparations